204 related articles for article (PubMed ID: 2045203)
1. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
Nygren P; Larsson R
Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
Larsson R; Nygren P
Int J Cancer; 1990 Jul; 46(1):67-72. PubMed ID: 2194983
[TBL] [Abstract][Full Text] [Related]
3. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
4. Verapamil and cyclosporin A sensitize human kidney tumor cells to vincristine in absence of membrane P-glycoprotein and without apparent changes in the cytoplasmic free Ca2+ concentration.
Nygren P; Larsson R
Biosci Rep; 1990 Apr; 10(2):231-7. PubMed ID: 1972632
[TBL] [Abstract][Full Text] [Related]
5. A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells.
Gruber A; Larsson R; Nygren P; Björkholm M; Peterson C
Leukemia; 1994 Jun; 8(6):985-9. PubMed ID: 7911547
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the P-gp pump function on leukemic cell membrane and proper application of its reversal agents with Calcein-AM and flow cytometry].
Lan ZJ; Tang YM; Shen HQ; Qian BQ; Ning BT; Chen YH
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):334-8. PubMed ID: 17697617
[TBL] [Abstract][Full Text] [Related]
7. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo.
Bier H
Acta Otolaryngol; 1991; 111(4):797-806. PubMed ID: 1950544
[TBL] [Abstract][Full Text] [Related]
8. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
Lopes EC; Scolnik M; Alvarez E; Hajos SE
Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
[TBL] [Abstract][Full Text] [Related]
9. Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein.
Botling J; Liminga G; Larsson R; Nygren P; Nilsson K
Int J Cancer; 1994 Jul; 58(2):269-74. PubMed ID: 7913083
[TBL] [Abstract][Full Text] [Related]
10. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
[TBL] [Abstract][Full Text] [Related]
11. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
Parekh H; Simpkins H
Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
[TBL] [Abstract][Full Text] [Related]
12. Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin.
Larsson R; Bergh J; Nygren P
Anticancer Res; 1991; 11(1):455-9. PubMed ID: 1850223
[TBL] [Abstract][Full Text] [Related]
13. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
[TBL] [Abstract][Full Text] [Related]
14. Effect of buthionine sulfoximine on the sensitivity to doxorubicin of parent and MDR tumor cell lines.
Crescimanno M; Borsellino N; Leonardi V; Flandina C; Flugy A; Rausa L; D'Alessandro N
J Chemother; 1994 Oct; 6(5):343-8. PubMed ID: 7861199
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
Naito M; Oh-hara T; Yamazaki A; Danki T; Tsuruo T
Cancer Chemother Pharmacol; 1992; 29(3):195-200. PubMed ID: 1370765
[TBL] [Abstract][Full Text] [Related]
16. R-dl-verapamil downmodulates multidrug resistance of KBv200 cells to vincristine and doxorubicin.
Fang G; Yang YL; Li JS; Zhang ZX
Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):647-50. PubMed ID: 10678132
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
Watanabe T; Tsuge H; Oh-Hara T; Naito M; Tsuruo T
Acta Oncol; 1995; 34(2):235-41. PubMed ID: 7718262
[TBL] [Abstract][Full Text] [Related]
18. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
Page RL; Hughes CS; Huyan S; Sagris J; Trogdon M
Anticancer Res; 2000; 20(5B):3533-8. PubMed ID: 11131658
[TBL] [Abstract][Full Text] [Related]
19. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
Peters RH; Jollow DJ; Stuart RK
Cancer Res; 1991 May; 51(10):2536-41. PubMed ID: 2021933
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
Ishida Y; Shimada Y; Shimoyama M
Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
